CAR T cell immunotherapy for human cancer
- PMID: 29567707
- DOI: 10.1126/science.aar6711
CAR T cell immunotherapy for human cancer
Abstract
Adoptive T cell transfer (ACT) is a new area of transfusion medicine involving the infusion of lymphocytes to mediate antitumor, antiviral, or anti-inflammatory effects. The field has rapidly advanced from a promising form of immuno-oncology in preclinical models to the recent commercial approvals of chimeric antigen receptor (CAR) T cells to treat leukemia and lymphoma. This Review describes opportunities and challenges for entering mainstream oncology that presently face the CAR T field, with a focus on the challenges that have emerged over the past several years. VSports手机版.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U. S V体育安卓版. Government Works. .
Publication types (V体育官网)
- VSports - Actions
- VSports - Actions
MeSH terms
- VSports app下载 - Actions
- VSports app下载 - Actions
- "V体育平台登录" Actions
- V体育安卓版 - Actions
- Actions (V体育官网入口)
- Actions (VSports手机版)
Substances
"V体育2025版" Grants and funding
LinkOut - more resources
Full Text Sources (VSports最新版本)
Other Literature Sources
Miscellaneous